Discovery of N-(4-(2-Amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a Selective and Orally Efficacious Inhibitor of the Met Kinase Superfamily-Reference-Cited by-同舟云学术

Discovery of N-(4-(2-Amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide (BMS-777607), a Selective and Orally Efficacious Inhibitor of the Met Kinase Superfamily

Published:2009-02-13 Issue:5 Volume:52 Page:1251-1254
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Schroeder Gretchen M.¹,An Yongmi¹,Cai Zhen-Wei¹,Chen Xiao-Tao¹,Clark Cheryl¹,Cornelius Lyndon A. M.¹,Dai Jun¹,Gullo-Brown Johnni¹,Gupta Ashok¹,Henley Benjamin¹,Hunt John T.¹,Jeyaseelan Robert¹,Kamath Amrita¹,Kim Kyoung¹,Lippy Jonathan¹,Lombardo Louis J.¹,Manne Veeraswamy¹,Oppenheimer Simone¹,Sack John S.¹,Schmidt Robert J.¹,Shen Guoxiang¹,Stefanski Kevin¹,Tokarski John S.¹,Trainor George L.¹,Wautlet Barri S.¹,Wei Donna¹,Williams David K.¹,Zhang Yingru¹,Zhang Yueping¹,Fargnoli Joseph¹,Borzilleri Robert M.¹

Affiliation:

1. Bristol-Myers Squibb Research and Development, P.O. Box 4000, Princeton, New Jersey, 08543-4000

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm801586s

Reference13 articles.

1. Targeting the c-MET signaling pathway for cancer therapy

2. Targeting the c-Met Signaling Pathway in Cancer: Fig. 1.

3. c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention

4. Roles of mesenchymal-epithelial interactions and hepatocyte growth factor-scatter factor (HGF-SF) in placental development

Cited by 256 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MERTK Inhibition as a Targeted Novel Cancer Therapy;International Journal of Molecular Sciences;2024-07-12

2. Mer receptor expression promotes multiple myeloma disease development via a cell-extrinsic mechanism;2024-04-30

3. Discovery of a 1,6-naphthyridin-4-one-based AXL inhibitor with improved pharmacokinetics and enhanced in vivo antitumor efficacy;European Journal of Medicinal Chemistry;2024-02

4. Structure-activity relationship study of 1,6-naphthyridinone derivatives as selective type II AXL inhibitors with potent antitumor efficacy;European Journal of Medicinal Chemistry;2024-02

5. Rh‐Catalyzed Chemodivergent [3+3] Annulations of Diazoenals and α‐Aminoketones: Direct Synthesis of Functionalized 1,2‐Dihydropyridines and Fused 1,4‐Oxazines;Chemistry – A European Journal;2024-01-22